Search Results

Results 21 - 30 of 35 for child health. (2.83 seconds)
  • Epilepsy linked to mood symptoms in pregnancy

    Stanford-led study gives new insight into how epilepsy, pregnancy and symptoms of mood disorders interact.

  • Magazine explores molecules within us

    The new issue of Stanford Medicine magazine features articles about the molecules that make us who we are and how understanding them can lead to medical discoveries and innovations.

  • Keto and Mediterranean good for diabetes

    In a trial of the two low-carb diets, both were similarly effective in controlling blood glucose. Keto’s more severe carb restrictions did not provide additional overall health benefits.

  • Immunosuppression-free kidney transplant

    Using a method they developed for stem cell transplants, a Stanford team has enabled children with immune disorders to receive a new immune system and a matching kidney from a parent.

  • Brain plasticity leads to worse seizures

    A brain mechanism needed for learning explains why epileptic seizures become more frequent, but a finding in rodents offers hope for treatment, according to a new study.

  • Transfusion boosts brain function

    In a Stanford study, sedentary mice appear to benefit from another same-aged mouse’s exercise — if they receive injections of its blood.

  • Common genetic profile linked to drug reaction

    New medications help many people with inflammatory conditions and may ease severe COVID-19, but they carry risks.

  • New members of National Academy of Medicine

    Maximilian Diehn, Mary Hawn, Michelle Monje and Carla Pugh are among the 100 members elected this year to the National Academy of Medicine.

  • Breast cancer mutations don’t lower survival rates

    Newly diagnosed breast or ovarian cancer patients who carry common cancer-associated mutations have similar or better short-term survival rates than those with no mutations, researchers report.

  • Study reveals immune therapy’s challenge

    CAR-T cell therapy works for many types of blood cancers, but more than half of patients relapse. A Stanford study provides a clue as to why.